Centene Corp. and Evolent Health, a value-based clinical and administrative solutions provider, have expanded their partnership to bring improved oncology care to Centene’s Medicare Advantage members. The collaboration seeks to offer more personalized and coordinated oncology care for seniors, with the goal of improving health outcomes and quality of life for MA members. Centene and its WellCare subsidiary currently serve 1,279,623 MA members, making it the sixth-largest insurer in that market nationally. Centene in January completed its sale of Magellan Specialty Health to Evolent.
Source: AIS’s Directory of Health Plans